Regenerative Medicine Report 2008

With its deep research strength, strong international collaborations and unique aggregated approach to intellectual property development, Canada is ripe with commercial potential in the field of regenerative medicine, according to this Regenerative Medicine Industry Report.

This report – the first in a series of sector analyses to come from MaRS – examines a range of criteria in the regenerative medicine industry, including government funding and support, world-class scientific research, coordinated commercialization strategy, regulatory environment and legislative constraints and determines that Canada ranks in the top five in all of those criteria, when compared to all other nations in the world.

This report on Canada's unique assets in regenerative medicine outlines a range of excellent opportunities for the commercial sector to propel top-ranked Canadian research from the lab into the marketplace. We have a rich history and outstanding scientific capacity in all areas of regenerative medicine, and Canada is well positioned for commercial leadership as applications in this important sector matures. 

Click here for the press release >>
Read the blog and comment on the report >>

GET THE REPORT

To download this report for free, please fill out the following fields.
Click here to read our privacy policy.

* indicates a required field. First Name* Last Name* Company* Position/Title* Email Address* Office Phone Number  

• Email Page
• Print Page
• Increase Font
• Decrease Font

MaRS BLOG

• So you want to be an entrepreneur!?
• A picture is worth… a couple hundred site visits
• All I really need to know about entrepreneurship I learned at Ironman

See more articles

MaRS FACTS

MaRS was created in 2000 by a group of visionary business and community leaders concerned about Canada’s performance in the innovation economy.